PDF-Thrombus or Tumor?

Gladwin Hui MD Jonathan Beaudoin MD Rishi Agrawal MD Brian Ghoshhajra MD Wilfred Mamuya MD PhD and Suhny Abbara MD Clinical History A 67 yearold woman presented with mild shortness of br. 7th EDITION ANATOMIC STAGE/PROGNOSTIC GROUPSOccult Carcinoma TX N0 Stage 0 Tis N0 NotesThe uncommon supercial spreading tumor of any size with its invasive component limited to the bronchial wall, w By: . Weigang. . wang. , . sumanta. . goswami. , Erik . sahai. , . jeffrey. . b. . wyckoff. , Jeffrey E. . Segall. and John S. . Condeelis. Presented By: Lana . Awad. and Sebastian Lukjan. Motivation of research, why they did what they did…. When do you Back Off ?. Dr. Madhu Sreedharan. MD, DM, MRCP (UK), FIC (. Aus. ), FRCP (L), FRCP (E), FSCAI, FACC. NIMS Heart Foundation. . Scope of the Talk. Evidence Based. Hemangiopericytoma. Spectrum in Brain, Head & Neck, and Spine—Pathological Correlations. Kwofie. M. 1. , . Moritani. T. 1. , . Vijapura. C. 1. , . Kademian. J. 1. , Kirby . P. 2. 1: Department of Diagnostic Radiology, University of Iowa Hospitals and Clinics, Iowa City, IA. Intervista a Federico . Cappuzzo. Background:. Programmed death-ligand 1 (PD-L1) expression on tumor cells (TC) or tumor-infiltrating immune cells (IC) is associated with OS, PFS and ORR in pts with advanced NSCLC treated with atezolizumab (anti-PDL1, MPDL3280A; Spigel et al, Spira et al, ASCO 2015), indicating that PD-L1 expression on both TC and IC is important for anti-tumor immunity. However, these 2 distinct expression patterns suggest the existence of previously unidentified NSCLC subtypes with distinct immunologic profiles. . Dr. . Sakir. . Volkan. . Erdogan. Bakirkoy. Dr. . Sadi. . Konuk. Training and Research Hospital. Signet ring tumor of the ovary is extremely rare kind of ovarian tumor. . In . the English literature less than twenty cases were reported . Monica Brown, MPH, PhD. . California Cancer Registry. Mary Paré, RN, BS. . Sutter Cancer Center, Sacramento. Katrina Bauer, MS, CTR. . California Cancer Registry. NAACCR 2009 Conference, June 13-19, San Diego. Ben Ho Park MD PhD. Johns Hopkins University. Financial Disclosures. I have financial relationships with commercial entities that are relevant to the content of this presentation.. Royalties from Horizon Discovery, LTD. PURPOSE invasive vascular elastography NIVE to characterize endoleaks and thrombus organization in a canine model of abdominal aortic aneurysm AAA after endovascular aneurysm repair EVAR with stentgra and emboli Peter Nagy • A thrombus is any solid object developing from the blood in vivo within the vascular system or heart . • Thrombosis is hemostasis in the wrong place . • Major compo M.D. (. Hom. ). Prof.. & . HoD. Department of Pathology. Thrombosis. Thrombosis . is the formation of a blood clot within the vascular system during life.. . The blood clot is adherent to the vessel wall. Intervista a Federico . Cappuzzo. Background:. Programmed death-ligand 1 (PD-L1) expression on tumor cells (TC) or tumor-infiltrating immune cells (IC) is associated with OS, PFS and ORR in pts with advanced NSCLC treated with atezolizumab (anti-PDL1, MPDL3280A; Spigel et al, Spira et al, ASCO 2015), indicating that PD-L1 expression on both TC and IC is important for anti-tumor immunity. However, these 2 distinct expression patterns suggest the existence of previously unidentified NSCLC subtypes with distinct immunologic profiles. . yrs. Gender: . nd. Location: pons. Diagnosis: DIPG/DMG H3.1 K27M. Pre-treatment: no prior treatment. Source: biopsy. Stage: WHO grade IV.  . Genetic mutations: . HIST1H3B (p.K28M). NTRK2 duplication (exons 11-16).